German physician-journalist Christoph Specht wrote to me about what he called an “unbelievably un-balanced book-selling segment on CNN.”
It was still another network TV news promotion of Dr. David Agus’ book, “The End of Illness.”
In the segment (which is no longer available online, but here’s the transcript), Agus urges listeners to consider daily statin and aspirin use. He says they can get a 90-day supply of a statin like Lipitor for $10 – and that this can “decrease your incidence of cancer by 40 percent.” He also says that daily aspirin can decrease your risk of death from cancer and heart disease.
Dr. Specht wrote to me:
“Understanding that Dr. David Agus focused on taking “Lipitor” and aspirin” as THE solution for preventing illnesses is one thing. Another is why Dr. Gupta limited his reply to just asking him whether this isn’t “pill-pushing”. There is so much more to say about such an unbalanced, one-sided claim as “Lipitor cuts the risk of getting cancer by 40%”. To say the least, why didn’t he mention that Lipitor and – of course – aspirin have considerable side effects that must be taken into account when discussing prevention for the entire population? As well as they might work in individuals (in terms of benefit/risk-ratio), this by no means can be extrapolated to the largest group we can think of – the population. Sorry Sanjay, but in this instance you could have done better. I know you can.”
I’ve heard from numerous observers who have concerns about the widespread and unquestioning promotion of Agus’ book and statements.
Yesterday I heard from some Canadian observers after his appearance on CBC radio.
Even Jon Stewart had Agus on The Daily Show and, while I almost always applaud Stewart’s toughness as an interviewer, he threw softball questions at Agus while affording him several minutes of free book promotion. (Maybe Stewart should leave health care topics to Stephen Colbert, whose health care-related parodies are far more insightful and incisive.)
If you missed it, please see our post from three weeks ago – A critical analysis of ABC & Bill Weir’s “lifesaving test” story – about that network’s week-long promotion of the book, one part of which was particularly troublesome.
Opinions on other issues in news, journals, PR, advertising, marketing
A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold
Comments (10)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Ken Leebow
February 8, 2012 at 10:03 amAll I can say is: My doctor advised me that taking an aspirin can be dangerous. Of course, in the proper situation, it is advisable to take an aspirin … consult with your trusted physician.
And, I proudly have the website … LifeWithoutLipitor.com.
In this “magic pill” obsessed society, it’s nice not to be taking any of them.
P.S. Charlie Rose didn’t throw any hardballs either.
Ken Leebow
February 8, 2012 at 10:03 amAll I can say is: My doctor advised me that taking an aspirin can be dangerous. Of course, in the proper situation, it is advisable to take an aspirin … consult with your trusted physician.
And, I proudly have the website … LifeWithoutLipitor.com.
In this “magic pill” obsessed society, it’s nice not to be taking any of them.
P.S. Charlie Rose didn’t throw any hardballs either.
Evilcyber
February 8, 2012 at 7:41 pmDo you wonder why that book is so heavily pushed or why it so heavily sells?
The first is marketing relying on a sensational claim, backed by an apparent authority and providing a simple solution to a complex problem. The second is – and always was – gullibility.
Evilcyber
February 8, 2012 at 7:41 pmDo you wonder why that book is so heavily pushed or why it so heavily sells?
The first is marketing relying on a sensational claim, backed by an apparent authority and providing a simple solution to a complex problem. The second is – and always was – gullibility.
Marilyn Mann
February 8, 2012 at 8:20 pmThere is no convincing evidence that statins lower the risk of cancer at all, much less by 40 percent. There are some observational studies that show an association between statins and lower risk of cancer, but meta-analyses of randomized controlled trials have found no effect of statins on cancer incidence or cancer death. It seems likely that the results of the observational studies are due to bias or confounding. David Agus should know better.
Joy
February 13, 2012 at 9:37 amIs it too much to ask these health journalists to take a little crash course in epidemiology? I don’t care if you are a brain surgeon Gupta. Learn your epi and start asking people to explain their numbers.
I Hate Quacks
May 10, 2012 at 1:20 amI don’t get it. Argus explicitly states that taken vitamins is dangerous yet recommends perfectly healthy adults take stains and aspirin. I skimmed the book without finishing it. Seems like bad science to me.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like